Liposomal chemotherapy in visceral leishmaniasis: an ultrastructural study of an intracellular pathway.
The intracellular fate of liposomes administered intracardially was examined in the liver and spleen of hamsters experimentally infected with Leishmania donovani. Separate groups of animals were treated with liposomes containing either an antileishmanial agent, a colloidal gold marker, or saline. Ultrastructural examinations of lysosomal interactions with the parasitophorous vacuole and with phagocytized liposomes were made. Lysosomes readily fused with the parasitophorous vacuoles but appeared to have little effect on the parasite, possibly due to the production of enzyme inhibitors. Liposomes rapidly became localized in lysosomes subsequent to endocytosis by macrophages. Morphologic evidence suggested that secondary lysosomes containing liposomal residues then fused with the parasitophorous vacuole. Aspects of one possible pathway are discussed which may account for the greatly enhanced effectiveness of liposomal chemotherapy for experimental visceral leishmaniasis.
D000818:Animals; D000965:Antimony / Q000627:therapeutic use; D006224:Cricetinae; D007728:Kupffer Cells / Q000378:metabolism / Q000469:parasitology; D007891:Leishmania / Q000502:physiology; D007898:Leishmaniasis, Visceral / Q000188:drug therapy* / Q000469:parasitology; D008081:Liposomes / Q000008:administration & dosage / Q000378:metabolism*; D008247:Lysosomes / Q000378:metabolism; D008264:Macrophages / Q000378:metabolism* / Q000469:parasitology; D008297:Male; D008536:Meglumine; D000077485:Meglumine Antimoniate; D008647:Mesocricetus; D008854:Microscopy, Electron; D009942:Organometallic Compounds; D010587:Phagocytosis; D013154:Spleen / Q000469:parasitology
D008081:Liposomes; D009942:Organometallic Compounds; D008536:Meglumine; D000077485:Meglumine Antimoniate; D000965:Antimony